Načítá se...
Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
Ovarian cancer is very treatable in the early stages of disease; however, it is usually detected in the later stages, at which time, treatment is no longer as effective. If discovered early (Stage I), there is a 90% chance of five-year survival. Therefore, it is imperative that early-stage biomarker...
Uloženo v:
| Vydáno v: | Biomark Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Libertas Academica
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4539101/ https://ncbi.nlm.nih.gov/pubmed/26327782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BIC.S28378 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|